Toxicities Related to Intraarterial Infusion of Cisplatin and Etoposide in Patients with Brain Tumors
Authors:
- 1 March 1999
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 42 (1) , 73-77
Abstract
Chemotherapy for malignant brain tumors has a limited efficacy largely due to restricted blood–brain barrier permeability for chemotherapeutic drugs. Intraarterial chemotherapy (IAC) has the...Keywords
This publication has 9 references indexed in Scilit:
- High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas: benefit for selected patients.1996
- Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420AJournal of Neuro-Oncology, 1995
- A randomized comparison of intra-arterial versus intravenous with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant gliomaJournal of Neurosurgery, 1992
- Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumorsCancer, 1991
- Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous systemJournal of Neurosurgery, 1984
- Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumorsCancer, 1984
- COMPARISONS OF CARMUSTINE, PROCARBAZINE, AND HIGH-DOSE METHYLPREDNISOLONE AS ADDITIONS TO SURGERY AND RADIOTHERAPY FOR THE TREATMENT OF MALIGNANT GLIOMA1983
- HUMAN CENTRAL NERVOUS-SYSTEM DISTRIBUTION OF CIS-DIAMMINEDICHLOROPLATINUM AND USE AS A RADIOSENSITIZER IN MALIGNANT BRAIN-TUMORS1982
- Theoretic limitations of intracarotid infusions in brain tumor chemotherapy.1977